FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * FROST PHILLIP MD ET AL   2. Issuer Name and Ticker or Trading Symbol CONTINUCARE CORP [CNU] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director __X__ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) 4400 BISCAYNE BOULEVARD 3. Date of Earliest Transaction (Month/Day/Year) 10/04/2011 (Street) MIAMI, FL 33137 4. If Amendment, Date Original Filed(Month/Day/Year) 6. Individual or Joint/Group Filing(Check Applicable Line) ___ Form filed by One Reporting Person _X_ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 10/04/2011   M   25,000 A $ 5.23 425,000 D   Common Stock 10/04/2011   M   25,000 A $ 1.78 450,000 D   Common Stock 10/04/2011   M   25,000 A $ 4.06 475,000 D   Common Stock 10/04/2011   M   25,000 A $ 2.97 500,000 D   Common Stock 10/04/2011   M   20,000 A $ 2.42 520,000 D   Common Stock 10/04/2011   M   25,000 A $ 2.48 545,000 D   Common Stock 10/04/2011   M   20,000 A $ 1.35 565,000 D   Common Stock 10/04/2011   D   565,000 D (1) 0 D   Common Stock 10/04/2011   D   24,771,604 D (1) 0 I Frost Gamma Investments Trust (2) Common Stock 10/04/2011   D   819,313 D (1) 0 I Frost Nevada Investments Trust (3)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Underlying Securities (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$ 5.23	10/04/2011		M			25,000	(4)	02/24/2021	Common Stock, par value $.0001	25,000	$ 0	0	D
Stock Option (Right to Buy)	$ 1.78	10/04/2011		M			25,000	(4)	03/12/2019	Common Stock, par value $.0001	25,000	$ 0	0	D
Stock Option (Right to Buy)	$ 4.06	10/04/2011		M			25,000	(4)	02/09/2020	Common Stock, par value $.0001	25,000	$ 0	0	D
Stock Option (Right to Buy)	$ 2.97	10/04/2011		M			25,000	(4)	02/07/2017	Common Stock, par value $.0001	25,000	$ 0	0	D
Stock Option (Right to Buy)	$ 2.42	10/04/2011		M			20,000	(4)	12/06/2015	Common Stock, par value $.0001	20,000	$ 0	0	D
Stock Option (Right to Buy)	$ 2.48	10/04/2011		M			25,000	(4)	02/05/2018	Common Stock, par value $.0001	25,000	$ 0	0	D
Stock Option (Right to Buy)	$ 1.35	10/04/2011		M			20,000	(4)	08/24/2014	Common Stock, par value $.0001	20,000	$ 0	0	D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
FROST PHILLIP MD ET AL 4400 BISCAYNE BOULEVARD MIAMI, FL 33137	X	X
Frost Gamma Investments Trust 4400 BISCAYNE BOULEVARD MIAMI, FL 33137		X
Frost Nevada Investments Trust 4400 BISCAYNE BOULEVARD MIAMI, FL 33137		X

Signatures

/s/ Phillip Frost, M.D., Individually and as Trustee of Frost Gamma Investments Trust and Frost Nevada Investments Trust		10/06/2011
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Disposed of pursuant to an Agreement and Plan of Merger, dated June 26, 2011, by and among Continucare Corporation, Metropolitan Health Networks, Inc. ("Metropolitan") and Cab Merger Sub, Inc., a wholly owned subsidiary of Metropolitan (the "Merger Agreement"), in exchange for $6.25 in cash, without interest, and 0.0414 of a share of Metropolitan common stock.
(2)	These securities are held by Frost Gamma Investments Trust, of which Phillip Frost, M.D. is the trustee and Frost Gamma Limited Partnership is the sole and exclusive beneficiary. Phillip Frost, M.D. is one of two limited partners of Frost Gamma Limited Partnership. The general partner of Frost Gamma Limited Partnership is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost?Nevada Corporation. Phillip Frost, M.D., is also the sole shareholder of Frost?Nevada Corporation.
(3)	These securities are held by Frost Nevada Investments Trust, of which Phillip Frost, M.D. is the trustee and Frost?Nevada Limited Partnership is the sole and exclusive beneficiary. Phillip Frost, M.D., is one of five limited partners of Frost?Nevada Limited Partnership and the sole shareholder of Frost?Nevada Corporation, the sole general partner of Frost?Nevada Limited Partnership.
(4)	These options were immediately exercisable on the grant date.
Remarks: Exhibit 99.1 Joint Filer Information Exhibit 99.2 Joint Filer Information

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.